Dereck Lively II and a Second Surgery in 14 Months: Dallas Mavericks Pay the Bill in a Contract Year

On December 12, the Dallas Mavericks confirmed that Dereck Lively II had undergone surgery on his right foot. It was the second such procedure inside 14 months. The 22-year-old center, listed at 2.16 meters and 104 kilograms, closed out the 2026-26 season after exactly seven games. Across two professional seasons he has appeared in 43 games. His career averages sit at 8.4 points, 7.0 rebounds and 1.5 blocks in 22.9 minutes per game. ESPN reported that Lively had not been cleared for training camp, and the team described his availability for opening night as undetermined. That is the full set of hard facts. Everything else is a problem Dallas has to solve on its own, and it does not live on the box score. Dallas is building around Cooper Flagg, the reigning Rookie of the Year. A roster with Flagg as its axis needs a center who touches the ball rarely, finishes efficiently and defends multiple coverages. Lively fits that mold precisely: he screens, rolls, cuts and catches above the rim. He does not need the ball in his hands to generate efficiency. At the other end he protects the rim and can switch when he gets screened. That archetype translates to playoff basketball. In the summer of 2026, Lively was one link in a run to the NBA Finals. Rim-running bigs who do not need the ball generally hold their value in the postseason because opponents cannot scheme them off the floor. Lively's problem has never been scheme. It is games played. The quality of the data deserves a clear statement. Across the 2026-25 and 2026-26 seasons, no performance metric has been published for Lively: no shooting splits, no impact metric, no on/off numbers. Calling him a significant part of the long-term core is an opinion, not a demonstrated fact. Forty-three games in two seasons is a fact, and it outweighs every opinion. Athletic, switchable, cheaply contracted centers are the kind of asset that contenders are built on. The league holds only a limited supply of that archetype. When a team loses an internal slot like that, it does not lose a player; it loses a cost advantage. Lively's rookie contract is in its final season. This is the pivot the ESPN report states but does not analyze. He enters a contract year right after a second surgery on the same foot. The NBA rookie-scale mechanism lets a team sign an extension before the deal expires, or let the player reach restricted free agency while retaining matching rights. For a 2.16-meter, 22-year-old center with two surgeries on the same foot in 14 months, matching rights become the cheapest available tool. There is no incentive for Dallas to push a long-term extension onto the table now. The market will set a price first, and the team will decide whether to match. Lively's salary cost is low because rookie-scale deals follow a fixed ladder. The largest loss therefore sits not in the payroll but in roster construction. Dallas loses a cheap, productive internal slot at the scarcest position on the floor. To replace it, they must enter the market and compete against the rest of the league for the same archetype. Technically, losing Lively changes two things. On offense, Dallas loses the dive-man threat in pick-and-roll and the second-chance scoring engine from offensive rebounds. The team must pivot to five-out configurations or a replacement-level center. Both are downgrades in spacing and finishing. On defense, they lose backline shot-blocking and the flexibility to choose between drop and switch. A 2.16-meter, 104-kilogram frame that still moves is difficult to replace in aggregate. Statistically, 43 games across two seasons dominates the entire dossier. It renders any per-36 comparison meaningless because the sample is too small. When the sample is too small, error bars widen, and every valuation becomes a labeled guess. A spreadsheet does not lie — only the person too lazy to read it fools himself. I once built a tracking sheet for 30 deals in a single summer, each row listing fee, salary, clauses and announcement date. Thirty deals in one summer, each line a promise — I still keep them for cross-checking today. Based on my experience tracking games and contract files, one rule repeats: for a player entering a contract year, the injury record matters as much as the performance record. The question is no longer how good Lively is, but how many nights he is available. The message that the team is not discouraged by Lively's progress is a communications posture. It answers a question about morale, not about probability. When an injury report leans on anonymous sourcing for reassurance instead of on-record statements with specific timetables, the team is managing the narrative. Reassurance does not reduce medical risk; it softens the headline. Public expectation around Lively is anchored to the memory of the 2026 Finals. That memory is doing most of the work keeping his perceived value high while recent production data stays thin. That is an expectation gap, and if Lively keeps missing time, the gap will correct itself downward without anyone announcing it. One point gets little airtime. For a team whose competitive window is only opening, the time pressure is not as severe as for a team at its peak. Dallas can afford to wait. That patience is good for Lively's health, but it also means nobody is committing to anything about his return date. Silence about a timetable is itself a form of information. I trust numbers more than people — because people know how to lie, while numbers only know how to be wrong. Here, the numbers say one simple thing: seven games before surgery, 43 games across two seasons, and a contract year that has just begun. Three markers are worth tracking. First, a cleared-for-basketball-activity announcement within the next two to six weeks, when training camp opens; that would be the first positive signal. Second, whether Dallas signs an outside center; such a deal would indicate reduced internal reliance. Third, the pace of extension talks over the next six to twelve months, where protection structures and games-played clauses will reveal how the market prices Lively. Data does not cut across a story — it tells a different one, and it is rarely wrong. For Dereck Lively II, that story is still in its first chapter, and the next chapter will be written in games played rather than in promises.